Wells Fargo Analysts Give Aflac (AFL) a $48.00 Price Target

Aflac (NYSE:AFL) has been assigned a $48.00 target price by analysts at Wells Fargo in a research report issued on Wednesday. The firm presently has a “hold” rating on the financial services provider’s stock. Wells Fargo’s target price would indicate a potential upside of 5.70% from the stock’s previous close.

Several other research analysts have also weighed in on AFL. JPMorgan Chase lowered their target price on shares of Aflac to $47.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 27th. Credit Suisse Group assumed coverage on shares of Aflac in a research report on Wednesday. They set a “neutral” rating and a $49.00 target price on the stock. Zacks Investment Research upgraded shares of Aflac from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a research report on Tuesday, April 3rd. Barclays lowered their target price on shares of Aflac to $45.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 21st. Finally, Morgan Stanley upped their target price on shares of Aflac from $22.75 to $46.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 27th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating, three have assigned a buy rating and two have assigned a strong buy rating to the company. Aflac presently has an average rating of “Hold” and an average target price of $46.25.

How to Become a New Pot Stock Millionaire

NYSE AFL opened at $45.41 on Wednesday. The stock has a market cap of $35,203.96, a P/E ratio of 13.36, a PEG ratio of 1.77 and a beta of 0.95. Aflac has a 52-week low of $36.40 and a 52-week high of $45.88. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.05 and a quick ratio of 0.05.



Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, April 25th. The financial services provider reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.08. The firm had revenue of $5.46 billion during the quarter, compared to analysts’ expectations of $5.48 billion. Aflac had a net margin of 20.18% and a return on equity of 12.29%. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.47 earnings per share. sell-side analysts predict that Aflac will post 3.91 EPS for the current fiscal year.

In other news, Director Joseph L. Moskowitz acquired 550 shares of Aflac stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average price of $89.13 per share, with a total value of $49,021.50. Following the completion of the purchase, the director now owns 9,263 shares of the company’s stock, valued at approximately $825,611.19. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider June P. Howard sold 2,648 shares of the company’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $90.33, for a total transaction of $239,193.84. The disclosure for this sale can be found here. Insiders sold 37,631 shares of company stock worth $2,919,118 over the last quarter. Company insiders own 3.00% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Green Square Capital LLC purchased a new position in shares of Aflac during the fourth quarter valued at approximately $236,000. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Aflac by 5.1% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 59,350 shares of the financial services provider’s stock valued at $5,210,000 after buying an additional 2,890 shares during the period. Certified Advisory Corp purchased a new position in shares of Aflac during the fourth quarter valued at approximately $143,000. KCM Investment Advisors LLC lifted its stake in shares of Aflac by 7.5% during the fourth quarter. KCM Investment Advisors LLC now owns 14,825 shares of the financial services provider’s stock valued at $1,301,000 after buying an additional 1,038 shares during the period. Finally, Penbrook Management LLC purchased a new position in shares of Aflac during the fourth quarter valued at approximately $307,000. 35.19% of the stock is currently owned by institutional investors and hedge funds.

WARNING: “Wells Fargo Analysts Give Aflac (AFL) a $48.00 Price Target” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://stocknewstimes.com/2018/04/26/wells-fargo-analysts-give-aflac-afl-a-48-00-price-target.html.

Aflac Company Profile

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Analyst Recommendations for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply